BMS747158

DRUG4 trials

Sponsors

Lantheus Medical Imaging

Conditions

Coronary Artery Disease (CAD)HealthyHealthy VolunteersIschemia

Phase 1

A Phase I Study in Healthy Volunteers to Assess Dosimetry and Safety Following Injection of BMS747158 at Stress

CompletedNCT00707538

Lantheus Medical ImagingHealthy Volunteers

Start: 2008-06-30End: 2008-10-31Updated: 2020-11-10

A Phase I Study in Healthy Volunteers to Assess Safety of BMS747158

CompletedNCT00707499

Lantheus Medical ImagingHealthy

Start: 2007-09-30End: 2008-06-30Updated: 2020-11-10

Phase 2

Development of 1-Day Rest/Stress Cardiac PET Perfusion Imaging Protocol of BMS747158

CompletedNCT00849108

Lantheus Medical ImagingIschemia

Start: 2009-01-31End: 2010-06-30Updated: 2015-10-14

Unknown Phase

A Long-term Follow-up Study to Evaluate the Predictive Value of BMS747158 in Patients Suspected of Coronary Artery Disease (CAD)

WithdrawnNCT01085162

Lantheus Medical ImagingCoronary Artery Disease (CAD)

Start: 2013-03-31End: 2015-03-31Updated: 2013-04-04